Zobrazeno 1 - 10
of 85
pro vyhledávání: '"V.B. Yagmur"'
Publikováno v:
Gastroenterologìa, Vol 57, Iss 3, Pp 159-165 (2023)
Background. Nonalcoholic fatty liver disease (NAFLD) is often accompanied by comorbid conditions such as obesity, type 2 diabetes, and cardiovascular diseases, which are risk factors for severe coronavirus disease (COVID-19). The latter is characteri
Externí odkaz:
https://doaj.org/article/31107e7cc3a6404badee8b21fd9c19cc
Publikováno v:
Gastroenterologìa, Vol 57, Iss 1, Pp 50-54 (2023)
Drug-induced liver injury (DILI) can be considered in cases of acute hepatitis by the exclusion of any disease-related causes. For several decades, anabolic steroids have been considered not only as drugs for treatment of diseases such as hypogonadis
Externí odkaz:
https://doaj.org/article/3abe029b8c7d4c3d8fdf63d000d6bda4
Publikováno v:
Gastroenterologìa, Vol 56, Iss 4, Pp 252-257 (2022)
The article presents a clinical case of refractory gastroesophageal reflux disease (GERD) in a female patient with non-alcoholic fatty liver disease and morbid obesity. A 38-year-old woman came to the clinic with complaints of heartburn up to 5–6 t
Externí odkaz:
https://doaj.org/article/003adc765d9d41cd9b707fbc18e6d3d3
Publikováno v:
Gastroenterologìa, Vol 56, Iss 2, Pp 110-117 (2022)
Background. There has been growing interest in the relationship between body mass and digestive diseases. There is no consensus on the calculation of the ideal human weight and the effect of its changes on gastrointestinal diseases. Materials and met
Externí odkaz:
https://doaj.org/article/b5f408207252443699edfc937ab53441
Publikováno v:
Gastroenterologìa, Vol 56, Iss 1, Pp 29-33 (2022)
Background. Non-alcoholic fatty liver disease (NAFLD) ranks first among chronic liver diseases and covers almost a quarter of the population. Enough data have been accumulated on the mutual influence of metabolic changes and steatosis of the liver of
Externí odkaz:
https://doaj.org/article/f0640cc402544802bb7b1a5bfa1ed92f
Publikováno v:
Gastroenterologìa, Vol 55, Iss 4, Pp 235-238 (2021)
Background. Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease. In recent years, disorders in the hemostasis system, their role in the progression of liver diseases and the development of cardiovascular complications i
Externí odkaz:
https://doaj.org/article/fe905bb7bd1a4936bfd31e84662632f2
Publikováno v:
Gastroenterologìa, Vol 55, Iss 1, Pp 14-20 (2021)
Background. According to the global studies of viral infection COVID-19, 14–76 % of patients have biochemical signs of liver damage. They are the result of both the direct action of the virus and a general inflammatory reaction and damage induced b
Externí odkaz:
https://doaj.org/article/e4e3c9ae6308462da0af637e3a8d92bd
Publikováno v:
Gastroenterologìa, Vol 55, Iss 1, Pp 26-31 (2021)
Background. It is known that disorders of the intestinal microbiota in patients with chronical liver disease (CLD) are associated with immune dysregulation. The process begins with a violation of the intestinal microbiota, leading to the development
Externí odkaz:
https://doaj.org/article/93b70aba2e8243babeb9c78a9e33d1ba
Autor:
Yu.M. Stepanov, N.Yu. Zavhorodnia, O.Yu. Zavhorodnia, I.S. Konenko, V.B. Yagmur, N.P. Dementij, O.P. Petishko
Publikováno v:
Zdorovʹe Rebenka, Vol 15, Iss 6, Pp 409-419 (2020)
Background. The ability of certain forms of non-alcoholic fatty liver disease (NAFLD), namely non-alcoholic steatohepatitis (NASH), to rapid progression and the formation of advanced liver fibrosis and cirrhosis raises the need for early diagnosis of
Externí odkaz:
https://doaj.org/article/494b491b84274800b6f9d2010a821cd2
Publikováno v:
Gastroenterologìa, Vol 53, Iss 4, Pp 230-238 (2019)
Background. The most important factors affecting the prognosis, tactics and results of the treatment of chronic diffuse liver diseases, comprising non-alcoholic fatty liver disease (NAFLD) and chronic hepatitis associated with virus C (HCV), include
Externí odkaz:
https://doaj.org/article/199ea7c28a634b6da564f56ec2a4f2f9